[ad_1]
The stock-market correction has not gone far enough, say strategists at Goldman Sachs, after the worst single day in nearly two years.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...